HCWB HCW Biologics Inc

Price (delayed)

$1.63

Market cap

$10.98M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$7.73

Enterprise value

$16.32M

Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 42
Highlights
HCW Biologics's equity has soared by 167% YoY and by 108% from the previous quarter
The net income has soared by 91% year-on-year and by 71% since the previous quarter
HCW Biologics's quick ratio has surged by 75% YoY but it has decreased by 22% QoQ

Key stats

What are the main financial stats of HCWB

HCWB stock price

How has the HCW Biologics stock price performed over time
Intraday
-2.98%
1 week
-22.01%
1 month
297.37%
1 year
-73.45%
YTD
67.94%
QTD
352.78%

Financial performance

How have HCW Biologics's revenue and profit performed over time
Revenue
$6.54M
Gross profit
$6.54M
Operating income
-$7.98M
Net income
-$2.29M
Gross margin
100%
Net margin
-35%
HCWB's operating margin has soared by 100% from the previous quarter and by 98% YoY
The company's net margin has surged by 100% QoQ and by 100% YoY
The net income has soared by 91% year-on-year and by 71% since the previous quarter
The operating income has surged by 65% year-on-year and by 39% since the previous quarter

Price vs fundamentals

How does HCWB's price correlate with its fundamentals

Growth

What is HCW Biologics's growth rate over time

Valuation

What is HCW Biologics stock price valuation
P/E
N/A
P/B
1.9
P/S
1.35
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.5
HCWB's EPS has soared by 69% year-on-year and by 27% since the previous quarter
HCW Biologics's equity has soared by 167% YoY and by 108% from the previous quarter
HCWB's price to sales (P/S) is 98% less than its last 4 quarters average of 82.4 and 98% less than its 5-year quarterly average of 56.6

Efficiency

How efficient is HCW Biologics business performance
HCWB's ROS has soared by 100% since the previous quarter and by 100% year-on-year
HCWB's return on invested capital has surged by 93% year-on-year and by 82% since the previous quarter
The ROA is up by 24% YoY and by 20% QoQ

Dividends

What is HCWB's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for HCWB.

Financial health

How did HCW Biologics financials performed over time
HCWB's total assets is 27% greater than its total liabilities
HCW Biologics's quick ratio has surged by 75% YoY but it has decreased by 22% QoQ
HCWB's total liabilities is down by 38% YoY
The company's debt is 14% higher than its equity
HCW Biologics's debt to equity has surged by 170% YoY but it has shrunk by 54% QoQ
HCW Biologics's equity has soared by 167% YoY and by 108% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.